Waltz Health Company Profile

Background

Overview

Waltz Health is a digital health company founded in 2021 by Mark Thierer and Jonathon Thierer, headquartered in Chicago, Illinois. The company focuses on enhancing transparency and reducing costs within the U.S. pharmaceutical supply chain by providing AI-driven solutions for prescription care. Waltz Health serves a diverse clientele, including payers, pharmacies, pharmacy benefit managers (PBMs), and self-insured employers. In August 2025, Waltz Health merged with EVERSANA, a leading provider of commercial services to the global life sciences industry.

Mission and Vision

Waltz Health's mission is to empower consumers with better access to prescription medications by leveraging technology to drive down costs and improve transparency. The company's vision is to create a more efficient and equitable pharmaceutical supply chain that benefits all stakeholders, from consumers to healthcare providers.

Primary Area of Focus

The company's primary focus is on developing AI-driven tools that manage prescription costs, aiming to make medications more affordable and accessible. Key offerings include 'Marketplace Search,' which allows users to compare prescription prices across various savings programs, and 'Waltz Connect,' an end-to-end solution for managing specialty medication coverage.

Industry Significance

Waltz Health plays a significant role in the digital health sector, particularly in the prescription cost management arena. By addressing the complexities and lack of transparency within the pharmaceutical supply chain, the company contributes to the broader movement towards more efficient and consumer-friendly healthcare solutions.

Key Strategic Focus

Core Objectives

Cost Reduction: Implementing technology-driven solutions to lower prescription drug costs for consumers and payers.

Transparency Enhancement: Providing clear and accessible information about medication pricing and availability.

Market Expansion: Broadening the reach of their solutions to various stakeholders within the healthcare ecosystem.

Specific Areas of Specialization

Prescription Cost Management: Utilizing AI to analyze and compare medication prices across different platforms.

Specialty Medication Coverage: Offering comprehensive solutions for managing high-cost specialty drugs.

Key Technologies Utilized

Artificial Intelligence (AI): Employing AI algorithms to optimize prescription routing and pricing strategies.

Data Analytics: Analyzing large datasets to identify cost-effective and clinically appropriate pharmacy options.

Primary Markets Targeted

Health Plans: Collaborating with insurers to integrate cost-saving solutions into their offerings.

Pharmacies: Partnering with pharmacy chains to enhance customer experience and loyalty.

Self-Insured Employers: Assisting employers in managing prescription benefits for their employees.

Financials and Funding

Total Funds Raised

As of November 2024, Waltz Health has raised a total of $55.9 million in funding.

Recent Funding Rounds

Series A Round (April 2022): Raised $35.4 million, led by GV (formerly Google Ventures), with participation from Define Ventures, Echo Health Ventures, Blue Venture Fund, Byers Capital, and Twine Ventures.

Series A1 Round (November 2024): Raised an additional $17.5 million, bringing the total funding to $55.9 million.

Notable Investors

GV (formerly Google Ventures): Led the Series A funding round.

Define Ventures: Participated in the Series A funding round.

Echo Health Ventures: Participated in the Series A funding round.

Blue Venture Fund: Participated in the Series A funding round.

Byers Capital: Participated in the Series A funding round.

Twine Ventures: Participated in the Series A funding round.

Intended Utilization of Capital

The funds raised are intended to scale Waltz Health's operations, invest in product development, and expand its team across all business areas to enhance its technology-driven solutions for prescription care.

Pipeline Development

Key Pipeline Candidates

Marketplace Search: An AI-driven tool that allows consumers to compare prescription prices across various savings programs.

Waltz Connect: An end-to-end solution for managing specialty medication coverage, including proprietary technology, patient engagement support, and a dynamic marketplace with a network of high-quality specialty pharmacies.

Stages of Development

Marketplace Search: Launched in April 2022, currently operational and integrated with multiple pharmacy chains.

Waltz Connect: Launched in August 2024, currently operational with partnerships with specialty pharmacies.

Target Conditions

Marketplace Search: Applicable to a wide range of prescription medications across various therapeutic areas.

Waltz Connect: Focused on high-cost specialty medications, including treatments for chronic conditions and complex diseases.

Anticipated Milestones

Marketplace Search: Expansion of partnerships with additional pharmacy chains and integration with more health plans.

Waltz Connect: Broader adoption among health plans and self-insured employers, with ongoing enhancements to the platform's capabilities.

Technological Platform and Innovation

Proprietary Technologies

Intelligent Specialty Engine: An AI-enabled prescription routing software that intuitively finds the best and most appropriate specialty pharmacy option based on specific criteria selected by each payer.

Significant Scientific Methods

AI Algorithms: Utilized to analyze large datasets for optimizing prescription routing and pricing strategies.

Data Analytics: Employed to identify cost-effective and clinically appropriate pharmacy options.

Leadership Team

Mark Thierer – Co-founder and CEO

Professional Background: Former CEO of OptumRx, with extensive experience in pharmacy benefit management and healthcare IT.

Key Contributions: Led the development and strategic direction of Waltz Health, focusing on leveraging technology to improve prescription care.

Jonathon Thierer – Co-founder

Professional Background: Data scientist with experience in healthcare analytics, previously worked at OptumRx.

Key Contributions: Contributed technical expertise in developing AI-driven solutions for prescription cost management.

Competitor Profile

Market Insights and Dynamics

The digital health market, particularly in prescription cost management, is experiencing significant growth. The global digital health market is projected to reach $660 billion by 2025, driven by advancements in AI and data analytics.

Competitor Analysis

GoodRx: Offers prescription discount cards and price comparison tools, generating $780 million in revenue in 2023.

Express Scripts: A major PBM managing prescription drug benefits for health plans and employers, with pharmacy services revenue of $172.7 billion in 2024.

Digital Pharmacist: Provides digital solutions to pharmacies, including patient engagement tools and online prescription management.

Strategic Collaborations and Partnerships

WellDyne Partnership: Integrated Waltz Connect into WellDyne's transparent PBM model, enhancing cost savings and consumer experience.

Reliance Rx Partnership: Added Reliance Rx to Waltz Health's specialty pharmacy network, providing cost-efficient fulfillment options for generic specialty medications.

Operational Insights

Waltz Health differentiates itself through its AI-driven technology, transparent pricing models, and strategic partnerships, positioning itself as a competitive player in the digital health sector.